[Current trends in the therapy of arteriosclerotic disease].
D000328:Adult; D000368:Aged; D001161:Arteriosclerosis / Q000188:drug therapy*; D002784:Cholesterol / Q000097:blood; D002914:Chylomicrons / Q000097:blood; D002994:Clofibrate / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D006949:Hyperlipidemias / Q000188:drug therapy; D000960:Hypolipidemic Agents / Q000627:therapeutic use*; D008055:Lipids / Q000097:blood; D008074:Lipoproteins / Q000097:blood; D008077:Lipoproteins, LDL / Q000097:blood; D008297:Male; D008875:Middle Aged; D011727:Pyridinolcarbamate / Q000627:therapeutic use*; D014280:Triglycerides / Q000097:blood
D002914:Chylomicrons; D000960:Hypolipidemic Agents; D008055:Lipids; D008074:Lipoproteins; D008077:Lipoproteins, LDL; D014280:Triglycerides; D011727:Pyridinolcarbamate; D002784:Cholesterol; D002994:Clofibrate
Orientamenti attuali in tema di terapia della malattia aterosclerotica